Chronic Pain and Complementary Therapies: The Challenge of Measuring Patient Benefit
- 1Patient Centred Outcomes Research Group (PCOR), Leeds Institute of Medical Research, Level 5, Clinical Sciences Building St James' University Hospital Leeds UK
- 2Centre for Pain Research, School of Health, Portland Way Leeds Beckett University Leeds UK
- 3Academic Unit of Palliative Care, Leeds Institute of Health Sciences Leeds University School of Medicine Leeds UK
Abstract
Rationale: Chronic pain remains a major challenge in healthcare despite advances in pharmaceutical management. Growing recognition of the biopsychosocial complexity of chronic pain has highlighted the need for approaches that reflect this multidimensional experience. Complementary therapies, used alongside mainstream treatments, are increasingly popular, yet evidence supporting their efficacy is limited. Randomised controlled trials (RCTs) have not generated findings sufficient to influence policy or practice, potentially because their outcome measures fail to capture what matters most to patients.
Methods: A keyword search of Ovid Medline, PubMed, the Cochrane Collaboration, and National Institute for Health and Care Excellence (NICE) guidance from 2010 onwards identified contemporary chronic primary pain guidelines and systematic reviews.
Results: Our narrative synthesis examines current approaches to chronic pain management, the prevalence of complementary therapy use, and the evidence underpinning efficacy. We critically consider whether RCT designs and reductionist outcome measures are appropriate for evaluating holistic interventions.
Conclusions: We argue that the unique components of complementary therapies must be understood as potential mediators of change. Shifting focus from narrow efficacy testing towards evaluating meaning, patient responses, and perceived utility may provide more relevant insights. Developing programme theories and logic models can clarify how complementary therapies work and guide the selection of suitable outcome measures for future research.
Related
- Complementary and Alternative Medicine Therapies in relation to Self-Reported Better Sleep across Racial and Ethnic Groups in the United States
- Heterotopic Cutaneous Adnexa Arising from the Ascending Colon Presenting as a Chronic Abdominal Wall Sinus: A Rare Congenital Anomaly and Diagnostic Challenge
- Chronic-Recurrent, Limb-Predominant Grover Disease in a Young Adult: A Clinicopathological Diagnostic Challenge
- Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody Vasculitis With Isolated Renal Presentation in an Older Female Patient: A Diagnostic and Therapeutic Challenge
- Respond through territorial action and with patient-partners to a health challenge related to addictions
BibTeX
@article{paley2026chronic,
title = {{Chronic Pain and Complementary Therapies: The Challenge of Measuring Patient Benefit}},
author = {Carole A. Paley and Matthew R. Mulvey and Mark I. Johnson},
journal = {Journal of Evaluation in Clinical Practice},
year = {2026},
month = nov,
doi = {10.1111/jep.70740},
url = {https://doi.org/10.1111/jep.70740},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Chronic Pain and Complementary Therapies: The Challenge of Measuring Patient Benefit
AU - Carole A. Paley
AU - Matthew R. Mulvey
AU - Mark I. Johnson
PY - 2026
DA - 2026/11/12
JO - Journal of Evaluation in Clinical Practice
DO - 10.1111/jep.70740
UR - https://doi.org/10.1111/jep.70740
AB - Rationale: Chronic pain remains a major challenge in healthcare despite advances in pharmaceutical management. Growing recognition of the biopsychosocial complexity of chronic pain has highlighted the need for approaches that reflect this multidimensional experience. Complementary therapies, used alongside mainstream treatments, are increasingly popular, yet evidence supporting their efficacy is limited. Randomised controlled trials (RCTs) have not generated findings sufficient to influence policy or practice, potentially because their outcome measures fail to capture what matters most to patients. Methods: A keyword search of Ovid Medline, PubMed, the Cochrane Collaboration, and National Institute for Health and Care Excellence (NICE) guidance from 2010 onwards identified contemporary chronic primary pain guidelines and systematic reviews. Results: Our narrative synthesis examines current approaches to chronic pain management, the prevalence of complementary therapy use, and the evidence underpinning efficacy. We critically consider whether RCT designs and reductionist outcome measures are appropriate for evaluating holistic interventions. Conclusions: We argue that the unique components of complementary therapies must be understood as potential mediators of change. Shifting focus from narrow efficacy testing towards evaluating meaning, patient responses, and perceived utility may provide more relevant insights. Developing programme theories and logic models can clarify how complementary therapies work and guide the selection of suitable outcome measures for future research.
SN - 1356-1294
SN - 1365-2753
ER -